Will NVIDIA 2x Over The Next Year?
The introduction of the Chinese generative AI model has created a storm on Wall Street, and tall trees are the first to bear the brunt of it. Big tech names have shown weaknesses and AI-related stocks have faced issues as the fear of the new-gen AI model, DeepSeek, and circumstances surrounding its creation spread through the market. » Read more about: Will NVIDIA 2x Over The Next Year? »
Read More
Market Commentary: When To Sell Your Stock, Precisely
Buying stocks is easy but when should you sell them? Today we’ll take a look at a specific example of precisely when to take profits, and move to the next best trading idea.
We’re going to use Upstart for our case study. In the chart below, you can see Upstart was in a a bullish trend since early May.
» Read more about: Market Commentary: When To Sell Your Stock, Precisely »
Read More
Alert: Buy Buffett’s Magic Line In The Sand
Investment Alert: Buy Occidental Petroleum (OXY) Under $57
Disclaimer: Investment Alerts have a medium to long-term time horizon. These do not constitute financial advice and you should contact a financial advisor before deciding whether it is appropriate for your individual circumstances.
This might be among the shorter trade alerts of the year but that won’t make it any less valuable if we’re right.
» Read more about: Alert: Buy Buffett’s Magic Line In The Sand »
Read More
Market Commentary: Are Only Fools Buying Netflix?
Netflix reported earnings recently and the share price plunged $40 on the day, down almost 8.5%. To anybody who could read the tea leaves, the reaction came as no surprise. But how do you read the tea leaves? Or in other words, what was the giveaway in the financials that led to investors realizing the risk to reward ratio was poor,
» Read more about: Market Commentary: Are Only Fools Buying Netflix? »
Read More
Stanley’s Latest Bold Bet, Should You Follow?
Billionaire Stanley Druckenmiller has been shaking up his portfolio lately, selling his entire stake in NVIDIA and most of his Palantir shares in order to diversify into more value-oriented stocks.
One of the most interesting buys Druckenmiller has made has been a 1.43 million share stake in Teva Pharmaceutical Industries (NYSE:TEVA).
» Read more about: Stanley’s Latest Bold Bet, Should You Follow? »
Read MoreThe Ivy
Is This Market Doomed?
This year headlines blared about the S&P 500 entering correction territory and the Nasdaq dipping into a bear market. For newer investors, it may feel like the sky is falling but seasoned traders know better, it’s just another chapter in a very old playbook.
The truth is, if you think this year has been rough,
» Read more about: Is This Market Doomed? »
Read MoreThe Spotlight
1 Royal ETF To Buy Without Hesitation
Five years ago when I last visited Saudi Arabia, the kingdom closely resembled the image many westerners might imagine.
First, it was challenging just to figure out how to get a visa. The answer lay in a dark room in a difficult-to-access New York building. Upon arrival, there was no such thing as socializing with women.
» Read more about: 1 Royal ETF To Buy Without Hesitation »
Read MoreThe Daily
Mistras Group (MG): One-Off $8.6M Loss Challenges Bullish Profitability Narrative
Mistras Group (MG) recently reported a major shift to profitability, with earnings averaging 71.1% growth each year over the past five years and the company’s net profit margin moving into positive territory during the last year. Shares are currently trading at $11.79, well below an estimated fair value of $22.02 based on the discounted cash flow approach.